NCLMEDIUM SIGNALFINANCIAL10-K

NCL executed multiple reverse stock splits while showing meaningful improvement in operating losses and cash flow generation despite reduced R&D spending.

The company implemented both 2-for-1 and 1-for-8 reverse stock splits in 2025-2026, typically indicating management's attempt to boost share price amid financial distress. However, the substantial reduction in operating losses and improved cash flow generation suggests the company may be stabilizing its operations, though this comes alongside significantly reduced R&D investment which could impact future competitiveness.

Comparing 2026-04-14 vs 2025-07-01View on EDGAR →
FINANCIAL ANALYSIS

NCL demonstrated meaningful financial improvement with operating losses substantially reduced and cash flow from operations showing significant improvement. The company meaningfully reduced R&D expenses while also lowering current liabilities and inventory levels. Despite these operational improvements, the multiple reverse stock splits and continued negative profitability indicate the company remains in a transitional phase as it works toward sustainable profitability.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+73.6%
-$4.7M-$1.2M

Operating cash flow surged 73.6% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+64.9%
-$4.8M-$1.7M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

R&D Expense
P&L
-58.8%
$1.9M$783K

R&D spending cut 58.8% — could signal cost discipline or concerning reduction in innovation investment.

Net Income
P&L
+38.6%
-$7.1M-$4.4M

Net income grew 38.6% — bottom-line growth signals improving overall business health.

Current Liabilities
Balance Sheet
-24.8%
$12.9M$9.7M

Current liabilities reduced — improved short-term financial position and working capital health.

Inventory
Balance Sheet
-24.6%
$2.6M$2.0M

Inventory reduced 24.6% — lean inventory management or demand outpacing supply.

Accounts Receivable
Balance Sheet
+18.8%
$2.6M$3.1M

Receivables grew 18.8% — monitor days sales outstanding for collection efficiency.

Total Liabilities
Balance Sheet
-13.5%
$13.0M$11.3M

Liabilities reduced 13.5% — deleveraging improves balance sheet strength and financial flexibility.

Current Assets
Balance Sheet
-13.1%
$6.8M$5.9M

Current assets declined 13.1% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2026-04-14
PRIOR — 2025-07-01
ADDED
(Note 16) Retrospectively restated for the effect of 2-for-1 reverse stock split.
On April 10 , 2026, the registrant had 53,733,083 shares of common stock and 625,000 shares of Series A Preferred Stock outstanding.
EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES 67 INDEX TO FINANCIAL STATEMENTS F-1 ITEM 16.
FORM 10-K SUMMARY 69 CONVENTIONS THAT APPLY TO THIS ANNUAL REPORT All share figures and per share price figures in this Annual Report on Form 10-K of Northann Corp.
(the Company ) for the fiscal year ended December 31, 2025, that are effective prior to October 7, 2025, have been updated retroactively to reflect the one-for-eight (1:8) reverse stock split of the shares of common stock of the Company, conducted by the Company on October 7, 2025, unless otherwise stated.
+7 more — sign up free →
REMOVED
On June 30, 2025 , the registrant had 95,464,400 shares of common stock and 5,000,000 shares of Series A Preferred Stock outstanding.
EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES 68 INDEX TO FINANCIAL STATEMENTS F-1 ITEM 16.
Department of Energy estimated that, compared to traditional manufacturing, additive manufacturing might slash waste and materials cost by nearly 90% and cut manufacturing energy use by half.
Our subsidiaries, NBS, NCP and Crazy Industry, own a portfolio of over 80 granted, pending or published patents.
Our revenue mainly consists of wholesale and retail of the vinyl flooring products, which are primarily marketed and sold in the United States and Canada.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →